Search Results
Results found for "Marie Sklodowska Curie"
- Dr. Hannes Schihada | Dr. GPCR Ecosystem
I was recently awarded a Marie Sklodowska Curie PostDoc Fellowship in order to investigate and find better
- A journey from Duke to McGill along the dopamine circuit
the nerve synapse might impact integrated behavior and what we might learn from these mechanisms to cure After a doctoral training at the Pierre and Marie Curie University in Paris and a short internship at the CNRS as a Research Fellow in 1987 in the INSERM Laboratory directed by Jean-Charles Schwartz in Paris From 91 to 94, he was an assistant professor at Duke University in North Carolina, working with Marc created the INSERM/CNRS laboratory on the "Neurobiology of Psychiatric Disorders", at the University of Paris-Sorbonne
- Dr. Bruno Giros | Dr. GPCR Ecosystem
the nerve synapse might impact integrated behavior and what we might learn from these mechanisms to cure After doctoral training at the Pierre and Marie Curie University in Paris and a short internship at Genentech the CNRS as a Research Fellow in 1987 in the INSERM Laboratory directed by Jean-Charles Schwartz in Paris From 91 to 94, he was an assistant professor at Duke University in North Carolina, working with Marc Neurobiology of Psychiatric Disorders," first in Créteil with Marion Leboyer, then at the University of Paris-Sorbonne
- Dr. GPCR Board | Dr. GPCR Ecosystem
Maria Waldhoer "I am a pharmacologist with a ~30 years background in academia and industry, working both Maria Waldhoer on the web LinkedIn T witter Pubmed Dr. GPCR About Dr. JoAnn Trejo "Dr. GPCR About Anne Marie Quinn "Anne Marie Quinn has a long and varied work experience in the biocomputing Anne Marie Quinn attended Yale University from 1998 to 2000, where they earned a Master of Public Health Anne Marie Quinn on the web Google Scholar The Org LinkedIn Twitter Dr. GPCR Enjoying the Dr.
- Dr. Andrew Tobin | Dr. GPCR Ecosystem
Andrew Tobin Andrew Tobin studied Biochemistry at Queen Mary College, the University of London obtaining
- Chris Langmead | Dr. GPCR Ecosystem
GPCR Podcast Strategic Partners Chris Langmead Chris Langmead is Professor, Deputy Director, and Better the field of psychiatry, where he has led multiple projects into late stage preclinical development, many Prior to joining Heptares, Chris was a neuroscience researcher at GlaxoSmithKline, UK (1998-2009). Chris serves on the editorial boards of the British Journal of Pharmacology, ACS Chemical Neuroscience
- Dr. Chris Tate | Dr. GPCR Ecosystem
Chris Tate About this episode Dr. Chris Tate obtained his Ph.D. from the University of Bristol in 1989 and then moved to the University Chris also worked on the E. coli multidrug transporter EmrE and obtained both 2D and 3D crystals as well Join me to learn more about Chris’s work and his role in founding Heptares which was later acquired by Chris Tate on the web LinkedIn ResearchGate Pubmed Google Scholar Sosei Heptares Wikipedia MRC Laboratory
- Removing the GPCR-mediated brake on exocytosis enhances insulin action, promotes adipocyte browning, and protects against diet-induced obesity
Lange and Annie Mary Lyle Chair in Cardiovascular Research, and Professor of Pharmacology, Ophthalmology Her laboratory has been involved in studying G protein coupled signal transduction for many years and
- CRO Advisory | Dr. GPCR Ecosystem
." - Anne Marie Quinn, CEO Montana Molecular Frequently Asked Questions 01 What kinds of CROs do you
- Dr. Kari Johnson | Dr. GPCR Ecosystem
Kari Johnson About this episode Dr. Kari Johnson is currently an assistant professor at the Uniformed Services University of the Health Sciences Kari completed her Ph.D. in Pharmacology at Vanderbilt University before continuing her training as a Join me and learn more about how Kari studies GPCRs in basal ganglia circuits following chronic alcohol Kari Johnson on the web LinkedIn Google Scholar Research Gate USU Twitter Dr.
- Yamina's Corner | Dr. GPCR Ecosystem
Anne Marie Quinn, CEO Montana Molecular Before working with Yamina, we were generating high-quality data
- master gpcr pharmacologic models before its too late | Dr. GPCR Ecosystem
They’re stalling because of slow decisions, misapplied models, and buried priorities.
- Annabelle Milner | Dr. GPCR Ecosystem
She began her Ph.D. at Imperial College London with Prof Aylin Hanyaloglu, Prof Gary Frost, and Dr.
- Dr. Amynah Pradhan | Dr. GPCR Ecosystem
Chris Evans at UCLA.
- Dr. Fiona Marshall | Dr. GPCR Ecosystem
Chris Tate and Dr. Richard Henderson at the Laboratory of Molecular Biology in Cambridge, UK.
- Dr. Randy Hall | Dr. GPCR Ecosystem
California at Irvine, studying the regulation of ionotropic glutamate receptors under the direction of Gary
- Custom Molecules, Fluorescent Probes: When Chemists Think Like Biologists with Dr. Maria Majellaro from Celtarys | Dr. GPCR Ecosystem
Maria Majellaro—and learn what their new partnership with Dr. curiosity to biotech force. “We started with GPCRs, but now we’re expanding to many new targets. Translating Science into Business Like many scientists-turned-entrepreneurs, Maria faced the challenge at the University of Bari (Italy) in 2018.
- New biosensor technologies are shedding light on GPCR dynamics directly in cells, offering exciting possibilities for multiplexing and miniaturization! Curious about how these advances could impact drug discovery? Check out the latest review on GPCR biosensors. Check out the latest GPCR news in the Ecosystem today! You’ll need to register but don’t worry, it’s Free! | Dr. GPCR Ecosystem
Curious about how these advances could impact drug discovery? Curious about how these advances could impact drug discovery?
- From Curiosity to Breakthrough: Ajay Yekkirala on GPCR Innovation | Dr. GPCR Ecosystem
GPCR Podcast Strategic Partners From Curiosity to Breakthrough: Ajay Yekkirala on GPCR Innovation What Ajay Yekkirala shares the pivotal moments that transformed him from a curious PhD student into a GPCR Ajay reveals how humility, curiosity, and collaboration fuel the future of drug discovery. translational innovation Biotech investors and strategic leaders seeking new drug development models Anyone curious His story is one of relentless curiosity, humility in the face of complexity, and an unshakable belief
- Can we preserve opioid pain relief without the side effects? 🔬 On Ep.166 of the Dr.GPCR Podcast, Ben Clements shares how positive allosteric modulators (PAMs) at the mu-opioid receptor could revolutionize treatment —with a 10x boost in methadone efficacy. Tune in for a masterclass on translational pharmacology, curiosity-driven science, and meaningful mentorship. 🎧 Full episode: Ep 166 with Dr. Ben Clements #GPCRresearch #DrGPCR #GPCRpodcast #OpioidPharmacology #DrugDiscovery | Dr. GPCR Ecosystem
Tune in for a masterclass on translational pharmacology, curiosity-driven science, and meaningful mentorship Ben Clements #GPCRresearch #DrGPCR #GPCRpodcast #OpioidPharmacology #DrugDiscovery Published on May 15 Tune in for a masterclass on translational pharmacology, curiosity-driven science, and meaningful mentorship
- Celtarys Research | Dr. GPCR Ecosystem
Maria Majellaro Co-Funder and CSO Dr. Maria Majellaro earned her degree in Pharmaceutical Chemistry and Technology from the University of Bari Maria Majellaro "We always start with the problem, then generate the right compound using our chemistry Maria Majellaro, CSO of Celtarys. “Working with Dr.
- 10 GPCR pharmacology lessons. Zero fluff. Launching July 1, Terry’s Corner gives you the clarity and confidence to make better decisions—starting with: • The role of pharmacology in discovery strategy • Black & Leff’s operational model—finally made practical • Binding curves, orthosteric vs allosteric function, and real vs apparent affinity • Molecular dynamics and how they guide ligand design • Why Terry built this—and how it sharpens your next move 📅 Learn anytime. New course every week. 📬 Subscribe to The Kenakin Brief → https://www.terrykenakin.com #GPCRscience #drugdiscovery #TerrysCorner #GPCRpharmacology #ligandbinding | Dr. GPCR Ecosystem
pharmacology in discovery strategy • Black & Leff’s operational model—finally made practical • Binding curves pharmacology in discovery strategy 🟢 Black & Leff’s operational model—finally made practical 🟢 Binding curves
- Did you know that certain ergot derivatives can produce wash-resistant signalling through the 5-HT2B receptor persisting for many hours without losing potency or efficacy? By using signalling assays, radioligand binding assay, and microscopy, Gaidarov et al. suggested that this phenomenon results from persistently/irreversibly internalised signalling receptor complexes. Check out the latest GPCR news in the Ecosystem today! You’ll need to register but don’t worry, it’s Free! ➡️ https://www.ecosystem.drgpcr.com/receptor-activation-and-signaling/mechanisms-of-constitutive-and-agonist-induced-5-ht2b-internalization%2C-persistent-endosomal-signaling-and-paradoxical-regulation-of-agonist-pharmacology #gpcr#drgpcr | Dr. GPCR Ecosystem
ergot derivatives can produce wash-resistant signalling through the 5-HT2B receptor persisting for many 2C-persistent-endosomal-signaling-and-paradoxical-regulation-of-agonist-pharmacology #gpcr#drgpcr Published on May ergot derivatives can produce wash-resistant signalling through the 5-HT2B receptor persisting for many
- Flash News: Your Hub for GPCR Insights and Scientific Conference Programs
Many talented scientists leave the field not because they lacked skill, but because the right opportunity This moment cuts straight to the heart of how many of us fell in love with GPCR biology — that realization Michelle’s story isn’t just about science.It’s about what happens when curiosity takes over. space to turn decades of industry experience into short, targeted insights that keep you ahead of the curve And why slow-dissociating allosteric inhibitors can reshape signaling curves for hours — or even days
- Dr. GPCR Podcast
GPCR Podcast - The Voice of the Community Whether you’re a scientist, student, or just curious, you’ll
- Chemical Probes for GPCR Imaging and Internalization with Dr. Johannes Broichhagen | Dr. GPCR Ecosystem
Curiosity, collaboration, and a love of translating chemical concepts into biological insight drive his
- Dr. Nariman Balenga | Dr. GPCR Ecosystem
Maria Waldhoer at the Medical University of Graz, Austria, and received my Ph.D. in Molecular Medicine At the height of curiosity, a seemingly naïve idea at the dinner table led to a side project by which
- Model. Predict. Discover. with Dr. Jens Carlsson | Dr. GPCR Ecosystem
Along the way, he reflects on key career moments, the role of mentorship, and how curiosity continues
- When to Walk, When to Run: Lessons from the GPCR Trenches with Dr. Ben Clements | Dr. GPCR Ecosystem
scaffolds like thiazolidines and xanthinediones, Ben is helping define how structurally different PAMs may “It doesn’t matter how many cool, fun tools you have. With clarity, curiosity, and a collaborative spirit, Ben reminds us that impactful science isn’t just
- Signals, pH, and Discovery : Cracking GPCR Mysteries with Dr. Ian Chronis | Dr. GPCR Ecosystem
how his experiences at the University of Chicago and the University of Michigan shaped his scientific curiosity






















